SOPHiA GENETICS S.A.
SOPH News Today: Stay Updated with the Latest SOPHiA GENETICS S.A. News in Real Time
Find SOPH news now at Meyka AI. Stay informed with the latest SOPHiA GENETICS S.A. stocks updates, including price news, market analysis, and expert insights.
MYGN Director Bisaro Paul Buys 7,500 Shares on May 14, 2026
Myriad Genetics director Bisaro Paul purchased 7,500 shares at $3.69 per share on May 14, 2026, signaling insider confidence in MYGN stock.
CTVA Corteva Earnings Beat: Q1 2026 Crushes Estimates
Corteva (CTVA) Q1 2026 earnings beat: $1.50 EPS vs $1.17 estimate, $4.91B revenue vs $4.64B. Stock down 2.5% post-earnings.
GENSF Initiated Neutral at Exane BNP Paribas April 2026
Exane BNP Paribas initiated Genus plc (GENSF) with a Neutral rating on April 27, 2026, citing balanced outlook for the animal genetics company.
SOPH Insider Selling: 7 Officers Dispose Shares April 22, 2026
SOPHiA GENETICS insiders sold 7,159 shares on April 20. CEO Camblong led with 4,486 shares at $5.21. Coordinated insider selling signal.
MYGN Insider Selling: Two Officers Dispose Shares April 16, 2026
Myriad Genetics insiders sell 2,015 shares on April 14. Chief Scientific Officer and COO dispose stock worth $9,893 combined.
Missing Girl Found Safe April 14: German Police Ends Search
11-year-old Emilia Sophia I. from Zirndorf found safe on April 14. Police withdraw public search after girl reported missing near Nuremberg.
April 10: Swiss Dairy Genetics Shift, Bull Liability Case Hit Farmers
Swiss dairy cows face a genetics shift as Holstein lines gain momentum and a leased-bull liability case ends in a cost-splitting deal. What it means for Swiss farm income, leasing terms, and insurance
Craig-Hallum Maintains Buy on Opus Genetics (IRD) March 2026
Craig-Hallum maintained Buy on Opus Genetics (IRD) March 11, 2026 — IRD analyst rating update and market implications
BTIG Maintains Buy on SOPHiA GENETICS S.A. (SOPH) March 03, 2026
BTIG maintains Buy on SOPHiA GENETICS S.A.; SOPH analyst rating unchanged March 03, 2026